LEXEO THERAPEUTICS INC(NASDAQ:LXEO) stock News

LXEO Latest News, Press Relases and Analysis

All

Press Releases

17 days ago - By: Chartmill - Mentions: NAK ACET BTM AEHR ...

Tuesday's session: gap up and gap down stocks

17 days ago - By: Chartmill - Mentions: NAK NVX AEHR APVO ...

Stay updated with the stocks that are on the move in today's pre-market session.

a day ago - By: Zacks Investment Research

Wall Street Analysts See a 108.23% Upside in Lexeo Therapeutics, Inc. (LXEO): Can the Stock Really Move This High?

4 days ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering

7 days ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement

8 days ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

16 days ago - By: Stocktwits

Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In

17 days ago - By: Benzinga - Mentions: SNWV CLRB APVO SPRB ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

17 days ago - By: Benzinga - Mentions: NNE APP DGNX NAK ...

James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday

17 days ago - By: Stocktwits - Mentions: IWMW UWM

Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process

17 days ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy

2 months ago - By: The Motley Fool

Lexeo Reports Q2 Loss as Costs Jump 129%

2 months ago - By: Lexeo Therapeutics

Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights

3 months ago - By: Yahoo Finance - Mentions: MSFT HSBC EBAY UNH ...

Meta, Microsoft upgraded: Wall Street's top analyst calls

4 months ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

4 months ago - By: Lexeo Therapeutics

Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics

5 months ago - By: Lexeo Therapeutics

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

6 months ago - By: Lexeo Therapeutics

Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights